Dr. Gary Phillip Lask, MD

Dr. Lask practices at San Gabriel Valley Childrens Surgery Center in Encino, California.

Dr. Lask's NPI, 1275567158, was assigned on July 10, 2006. Dr. Lask holds California license A35542.

Dr. Lask's primary practice is San Gabriel Valley Childrens Surgery Center, at 16260 W Ventura Blvd, Encino, CA 91436 in Los Angeles County. The practice phone is (818) 814-9800.

Dr. Lask's primary practice is San Gabriel Valley Childrens Surgery Center in Encino, California. The medical group on file is Indianer, Lask & Rosenzweig, M.D.'s Dermatology Group. Dmand AI also links Dr. Lask to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lask practices. Vendor and product names are available with a free account.

Dermatology is Dr. Lask's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Lask is licensed in California.

CMS data shows 2,828 Medicare services from Dr. Lask across 13 procedure codes in 2024, for 555 Medicare patients. Medicare paid $172,439 for them. Every service was in an office.

CMS counts 555 Medicare patients who saw Dr. Lask in 2024. The largest group is 75 to 84, with 274 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lask's median patient age at 78, with 45% women.

In 2024, Dr. Lask wrote 238 Medicare Part D claims for 124 patients. 96% of them were for generic drugs. CMS names the drug for 158 of them, across 7 drugs with 11 or more claims each, at $1,952 in total drug cost. In 2023, CMS named 156 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Lask for performance year 2024, reported individually. Dr. Lask accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 549 procedures of skin biopsy by Dr. Lask, more than 96% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin cancer: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Lask, published from 2016 to 2023. 2019 was the busiest year, with 2. Dr. Lask has published most often in Dermatol Surg. Dr. Lask's most frequent co-authors are Cameron D. Chesnut, MD, Nima M. Gharavi, MD, PhD and Margit Lai Wun Juhasz, MD.

CMS Open Payments shows 54 general payments to Dr. Lask from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $187.